Telesis Bio Inc Prix / Ventes
Quel est le Prix / Ventes de Telesis Bio Inc?
Le Prix / Ventes de Telesis Bio Inc est 160.32
Quelle est la définition de Prix / Ventes?
Le rapport prix / ventes est le prix des actions d'une entreprise par rapport à ses revenus.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Prix / Ventes des entreprises dans Health Care secteur sur NASDAQ par rapport à Telesis Bio Inc
Que fait Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Entreprises avec prix / ventes similaire à Telesis Bio Inc
- DynaCERT a Prix / Ventes de 157.05
- Desert Mountain a Prix / Ventes de 157.95
- POET Technologies a Prix / Ventes de 158.69
- Kintor Pharmaceutical a Prix / Ventes de 159.80
- Interlapse Technologies a Prix / Ventes de 160.21
- Diatreme Resources a Prix / Ventes de 160.30
- Telesis Bio Inc a Prix / Ventes de 160.32
- RiverFort Global Opportunities plc a Prix / Ventes de 162.01
- dynaCERT a Prix / Ventes de 162.66
- Ocumension Therapeutics Co Ltd a Prix / Ventes de 162.95
- Prairie Mining a Prix / Ventes de 163.76
- Argenica Therapeutics a Prix / Ventes de 163.80
- Lexagene a Prix / Ventes de 165.17